Debt-to-equity of Perspective Therapeutics, Inc. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Perspective Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • Perspective Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 18%, a 2.9% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Perspective Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 18% -0.54% -2.9% 30 Sep 2025
Q2 2025 17% +0.19% +1.1% 30 Jun 2025
Q1 2025 16% -2.1% -12% 31 Mar 2025
Q4 2024 17% +3.5% +25% 31 Dec 2024
Q3 2024 18% +8.8% +92% 30 Sep 2024
Q2 2024 17% +8.5% +98% 30 Jun 2024
Q1 2024 18% +11% +155% 31 Mar 2024
Q4 2023 14% +7.8% +129% 31 Dec 2023
Q3 2023 9.6% +4% +71% 30 Sep 2023
Q2 2023 8.7% +4% +86% 30 Jun 2023
Q1 2023 7.2% +2.7% +60% 31 Mar 2023
Q4 2022 6.1% +1.5% +34% 31 Dec 2022
Q3 2022 5.6% +0.03% +0.54% 30 Sep 2022
Q2 2022 4.7% -3.1% -40% 30 Jun 2022
Q1 2022 4.5% -8.4% -65% 31 Mar 2022
Q4 2021 4.5% -36% -89% 31 Dec 2021
Q3 2021 5.6% -46% -89% 30 Sep 2021
Q2 2021 7.7% -41% -84% 30 Jun 2021
Q1 2021 13% -28% -68% 31 Mar 2021
Q4 2020 40% +7.2% +22% 31 Dec 2020
Q3 2020 52% +24% +87% 30 Sep 2020
Q2 2020 49% +27% +122% 30 Jun 2020
Q1 2020 41% +15% +58% 31 Mar 2020
Q4 2019 33% +6.4% +24% 31 Dec 2019
Q3 2019 28% +2% +7.9% 30 Sep 2019
Q2 2019 22% -3.3% -13% 30 Jun 2019
Q1 2019 26% +6.8% +36% 31 Mar 2019
Q4 2018 27% +10% +63% 31 Dec 2018
Q3 2018 26% +12% +83% 30 Sep 2018
Q2 2018 25% +13% +101% 30 Jun 2018
Q1 2018 19% +7.6% +67% 31 Mar 2018
Q4 2017 16% +4.9% +43% 31 Dec 2017
Q3 2017 14% +2.4% +21% 30 Sep 2017
Q2 2017 13% +1.2% +11% 30 Jun 2017
Q1 2017 11% 0% 0% 31 Mar 2017
Q4 2016 11% +0.88% +8.4% 31 Dec 2016
Q3 2016 12% +1.8% +19% 30 Sep 2016
Q2 2016 11% +1.9% +20% 30 Jun 2016
Q1 2016 11% +1.8% +19% 31 Mar 2016
Q4 2015 10% +0.64% +6.5% 31 Dec 2015
Q3 2015 9.8% -1.6% -14% 30 Sep 2015
Q2 2015 9.5% -4.5% -32% 30 Jun 2015
Q1 2015 9.6% -8.3% -47% 31 Mar 2015
Q4 2014 9.8% -17% -63% 31 Dec 2014
Q3 2014 11% -15% -57% 30 Sep 2014
Q2 2014 14% -10% -42% 30 Jun 2014
Q1 2014 18% -5.7% -24% 31 Mar 2014
Q4 2013 27% +3.5% +15% 31 Dec 2013
Q3 2013 26% +2.4% +9.8% 30 Sep 2013
Q2 2013 24% -3% -11% 30 Jun 2013
Q1 2013 24% -1.7% -6.7% 31 Mar 2013
Q4 2012 23% 31 Dec 2012
Q3 2012 24% 30 Sep 2012
Q2 2012 27% 30 Jun 2012
Q1 2012 25% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.